Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery.

Allergic Rhinitis Budesonide Hydroxypropyl- β -cyclodextrin Microparticles Mucoadhesion Nasal delivery Spray-drying Thiomers

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Jun 2021
Historique:
received: 17 01 2021
revised: 18 05 2021
accepted: 19 05 2021
pubmed: 25 5 2021
medline: 22 6 2021
entrez: 24 5 2021
Statut: ppublish

Résumé

Budesonide (BUD) is used as first choice therapy for the treatment of allergic rhinitis, a chronic allergic-immune condition with an increased incidence in the pediatric population. The main problem of BUD nasal formulations is related to its poor aqueous solubility (S

Identifiants

pubmed: 34029665
pii: S0378-5173(21)00533-0
doi: 10.1016/j.ijpharm.2021.120728
pii:
doi:

Substances chimiques

Sulfhydryl Compounds 0
2-Hydroxypropyl-beta-cyclodextrin 1I96OHX6EK
Budesonide 51333-22-3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120728

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Giuseppe Francesco Racaniello (GF)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Valentino Laquintana (V)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Simona Summonte (S)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy; Thiomatrix Forschungs- und Beratungs GmbH, Research Center Innsbruck, Trientlgasse 65, 6020 Innsbruck, Austria.

Angela Lopedota (A)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Annalisa Cutrignelli (A)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Antonio Lopalco (A)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Massimo Franco (M)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.

Andreas Bernkop-Schnürch (A)

Thiomatrix Forschungs- und Beratungs GmbH, Research Center Innsbruck, Trientlgasse 65, 6020 Innsbruck, Austria; Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria.

Nunzio Denora (N)

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy. Electronic address: nunzio.denora@uniba.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH